<?xml version="1.0" encoding="UTF-8"?>
<collection xmlns="http://www.loc.gov/MARC21/slim">
 <record>
  <leader>     caa a22        4500</leader>
  <controlfield tag="001">445292393</controlfield>
  <controlfield tag="003">CHVBK</controlfield>
  <controlfield tag="005">20180317142532.0</controlfield>
  <controlfield tag="007">cr unu---uuuuu</controlfield>
  <controlfield tag="008">170323e20100601xx      s     000 0 eng  </controlfield>
  <datafield tag="024" ind1="7" ind2="0">
   <subfield code="a">10.1007/s11626-010-9279-1</subfield>
   <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="035" ind1=" " ind2=" ">
   <subfield code="a">(NATIONALLICENCE)springer-10.1007/s11626-010-9279-1</subfield>
  </datafield>
  <datafield tag="245" ind1="0" ind2="0">
   <subfield code="a">Activation of CD74 inhibits migration of human mesenchymal stem cells</subfield>
   <subfield code="h">[Elektronische Daten]</subfield>
   <subfield code="c">[Bonnie Barrilleaux, Benjamin Fischer-Valuck, Jennifer Gilliam, Donald Phinney, Kim O'Connor]</subfield>
  </datafield>
  <datafield tag="520" ind1="3" ind2=" ">
   <subfield code="a">Therapeutic administration of mesenchymal stem cells (MSCs) by systemic delivery utilizes the innate ability of the cells to home to damaged tissues, but it can be an inefficient process due to a limited knowledge of cellular cues that regulate migration and homing. Our lab recently discovered that a potent pro-inflammatory cytokine, macrophage migration inhibitory factor (MIF), inhibits MSC migration. Because MIF may act on multiple cellular targets, an activating antibody (CD74Ab) was employed in this study to examine the effect of one MIF receptor, CD74 (major histocompatibility complex class II-associated invariant chain), on MSC motility. CD74 activation inhibits in a dose-dependent manner up to 90% of in vitro migration of MSCs at 40μg/ml CD74Ab (p &lt; 0.001), with consistent effects observed among three MSC donor preparations. A blocking peptide from the C-terminus of CD74 eliminates the effect of CD74Ab on MSCs. This suggests that MIF may act on MSCs, at least in part, through CD74. Late-passage MSCs exhibit less chemokinesis than those at passage 2. However, MSCs remain responsive to CD74 activation during ex vivo expansion: MSC migration is inhibited ∼2-fold in the presence of 5µg/ml CD74Ab at passage 9 vs. ∼3-fold at passage 2 (p &lt; 0.001). Consistent with this result, there were no significant differences in CD74 expression at all tested passages or after CD74Ab exposure. Targeting CD74 to regulate migration and homing potentially may be a useful strategy to improve the efficacy of a variety of MSC therapies, including those that require ex vivo expansion.</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
   <subfield code="a">The Society for In Vitro Biology, 2010</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Mesenchymal stem cells</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">CD74</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Major histocompatibility complex class II-associated invariant chain</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Chemokinesis</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Migration</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Barrilleaux</subfield>
   <subfield code="D">Bonnie</subfield>
   <subfield code="u">Department of Chemical and Biomolecular Engineering, Tulane University, Lindy Boggs Center Room 300, 70118, New Orleans, LA, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Fischer-Valuck</subfield>
   <subfield code="D">Benjamin</subfield>
   <subfield code="u">Department of Chemical and Biomolecular Engineering, Tulane University, Lindy Boggs Center Room 300, 70118, New Orleans, LA, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Gilliam</subfield>
   <subfield code="D">Jennifer</subfield>
   <subfield code="u">Department of Chemical and Biomolecular Engineering, Tulane University, Lindy Boggs Center Room 300, 70118, New Orleans, LA, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Phinney</subfield>
   <subfield code="D">Donald</subfield>
   <subfield code="u">Department of Molecular Therapeutics, The Scripps Research Institute, 33458, Jupiter, FL, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">O'Connor</subfield>
   <subfield code="D">Kim</subfield>
   <subfield code="u">Department of Chemical and Biomolecular Engineering, Tulane University, Lindy Boggs Center Room 300, 70118, New Orleans, LA, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="773" ind1="0" ind2=" ">
   <subfield code="t">In Vitro Cellular &amp; Developmental Biology - Animal</subfield>
   <subfield code="d">Springer-Verlag</subfield>
   <subfield code="g">46/6(2010-06-01), 566-572</subfield>
   <subfield code="x">1071-2690</subfield>
   <subfield code="q">46:6&lt;566</subfield>
   <subfield code="1">2010</subfield>
   <subfield code="2">46</subfield>
   <subfield code="o">11626</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2="0">
   <subfield code="u">https://doi.org/10.1007/s11626-010-9279-1</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="908" ind1=" " ind2=" ">
   <subfield code="D">1</subfield>
   <subfield code="a">research-article</subfield>
   <subfield code="2">jats</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">856</subfield>
   <subfield code="E">40</subfield>
   <subfield code="u">https://doi.org/10.1007/s11626-010-9279-1</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Barrilleaux</subfield>
   <subfield code="D">Bonnie</subfield>
   <subfield code="u">Department of Chemical and Biomolecular Engineering, Tulane University, Lindy Boggs Center Room 300, 70118, New Orleans, LA, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Fischer-Valuck</subfield>
   <subfield code="D">Benjamin</subfield>
   <subfield code="u">Department of Chemical and Biomolecular Engineering, Tulane University, Lindy Boggs Center Room 300, 70118, New Orleans, LA, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Gilliam</subfield>
   <subfield code="D">Jennifer</subfield>
   <subfield code="u">Department of Chemical and Biomolecular Engineering, Tulane University, Lindy Boggs Center Room 300, 70118, New Orleans, LA, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Phinney</subfield>
   <subfield code="D">Donald</subfield>
   <subfield code="u">Department of Molecular Therapeutics, The Scripps Research Institute, 33458, Jupiter, FL, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">O'Connor</subfield>
   <subfield code="D">Kim</subfield>
   <subfield code="u">Department of Chemical and Biomolecular Engineering, Tulane University, Lindy Boggs Center Room 300, 70118, New Orleans, LA, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">773</subfield>
   <subfield code="E">0-</subfield>
   <subfield code="t">In Vitro Cellular &amp; Developmental Biology - Animal</subfield>
   <subfield code="d">Springer-Verlag</subfield>
   <subfield code="g">46/6(2010-06-01), 566-572</subfield>
   <subfield code="x">1071-2690</subfield>
   <subfield code="q">46:6&lt;566</subfield>
   <subfield code="1">2010</subfield>
   <subfield code="2">46</subfield>
   <subfield code="o">11626</subfield>
  </datafield>
  <datafield tag="900" ind1=" " ind2="7">
   <subfield code="a">Metadata rights reserved</subfield>
   <subfield code="b">Springer special CC-BY-NC licence</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="898" ind1=" " ind2=" ">
   <subfield code="a">BK010053</subfield>
   <subfield code="b">XK010053</subfield>
   <subfield code="c">XK010000</subfield>
  </datafield>
  <datafield tag="949" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="F">NATIONALLICENCE</subfield>
   <subfield code="b">NL-springer</subfield>
  </datafield>
 </record>
</collection>
